| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -491,024 | -402,919 |
| Proceeds from note payable - related party | 100,000 | - |
| Net cash provided by financing activities | 100,000 | - |
| Net change in cash | -391,024 | -402,919 |
| Cash and cash equivalents at beginning of period | 438,174 | - |
| Cash and cash equivalents at end of period | 47,150 | - |
Translational Development Acquisition Corp. (TDACU)
Translational Development Acquisition Corp. (TDACU)